Skip Navigation
Skip to contents
Results by Year

View Wide

Filter

ARTICLE TYPE

PUBLICATION DATE

4 results
Display

Assessment of thrombin-activatable fibrinolysis inhibitor (TAFI) activation in acquired hemostatic dysfunction: a diagnostic challenge

Kim HK

No abstract available.
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Elevated levels of activated and inactivated thrombin-activatable fibrinolysis inhibitor in patients with sepsis

Park R, Song J, An SS

BACKGROUND: In sepsis, large scale inflammatory responses can cause extensive collateral damage to the vasculature, because both coagulation and fibrinolysis are activated unevenly. Thrombin-activatable fibrinolysis inhibitor (TAFI) plays a role...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Plasma Fibrinolysis Inhibitor Levels in Acute Stroke Patients with Thrombolysis Failure

Kim SH, Han SW, Kim EH, Kim DJ, Lee KY, Kim DI, Heo JH

BACKGROUND AND PURPOSE: Thrombolytics-induced recanalization fails in a significant portion of patients with ischemic stroke, which is partly due to the resistance of clots to lysis by thrombolytic agents. The...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
The Significance of Thrombin Activable Fibrinolysis Inhibitor in Ischemic Stroke

Kim YC, Lee YK, Park MJ, Kang HJ, Kang SH, Cho HC, Lee BC, Yu KH

  • KMID: 2143202
  • Korean J Lab Med.
  • 2004 Dec;24(6):347-351.
BACKGROUND: Thrombin/thrombomodulin complex activates thrombin activable fibrinolysis inhibitor (TAFI) to active TAFI (TAFIa), which in turn catalyzes the hydrolysis of C-terminal lysine residues of partially degraded fibrin. The fibrin that...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close

Go to Top

Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr